12 Recruiting Melanoma Phase 3 Clinical Trials
Active phase 3 studies for melanoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Melanoma studiesPhase 3 Studies for Melanoma
🔵 Active, Not Recruiting Phase3
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
📍 University of California San Francisco — San Francisco, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
📍 Centro Oncologico Korben — CABA, Buenos Aires
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
📍 Adventist Health System/Sunbelt, Inc. — Orlando, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma
📍 Local Institution - 0125 — Phoenix, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
📍 UC San Diego — La Jolla, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma
📍 Local Institution - 0088 — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
📍 UC San Diego — La Jolla, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma
📍 Cancer and Blood Specialty clinic — Long Beach, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma
📍 Local Institution - 0010 — Tucson, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)
📍 Highlands Oncology Group ( Site 1943) — Springdale, Arkansas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)
📍 University of Arizona Cancer Center ( Site 0121) — Tucson, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
View Study & Checklist ➔